Skip to main content
. 2010 Oct 29;77(1):201–210. doi: 10.1128/AEM.01371-10

TABLE 2.

Bacterial plasmids constructed in this study

Plasmid Descriptiona Constructionb
Vector Insert Digestion/oligonucleotides (5′-3′)
Recombination substrates
    pCIG1110 oriT1(63-330mut)† pCIG1028 pCMS13 AACTCTAGAACCCAATGCGCATAGCG
AACAAGCTTCCTCTCCCGTAGTGTTAC
    pCIG1116 oriT1 HuX (15+3) (−7)‡ pCIG1028 Human DNA CCATCTAGATTAGACACAGGCTCTACTCACACAG
TACAAGCTTAAAAATTCAACACAGCCTCTAAGTG
    pCIG1117 oriT1 Hu5 (15+3) (−10)‡ pCIG1028 Human DNA CCATCTAGATCTAAGATGCAGTAAGATCCCAGAC
TACAAGCTTTCAAGATTAGTGAGCAAGAAATGTG
    pCIG1122 oriT1 Hu18 (10+2)‡ pCIG1028 Human DNA CCATCTAGACCTTGAACCTATTCTGCCCATA
TACAAGCTTTCAAGGCTCTTGATGTTTGAGA
    pCIG1126 oriT1 Hu5b (13+1)‡ pCIG1028 Human DNA CCATCTAGAAGCTATGCACAACAGCATGG
TACAAGCTTAATCCCAATATTTGACCACCA
    pCIG1127 oriT1 Hu7 (12+3)‡ pCIG1028 Human DNA CCATCTAGACCTGGCGATAGAGCAAGACT
TACAAGCTTCTGACCACCTGCTCCAAAAT
Plasmids used for intragenic complementation assays
    pCIG1070 pSU19::TrwC (N450) pSU19 pCIG1051 XbaI/BamHI
    pCIG1086 pSU19::TrwC pSU19 pSU1621 XbaI/BamHI
    pCIG1103 pSU19::TrwC (N600) pSU19 pCIG1099 XbaI/BamHI
    pLA35 pSU19::TrwC (N293) pSU19 pSU1600 XbaI/BamHI
Plasmids used for yeast nuclear import/export assays
    pCIG1133 pNIA::TrwC (N600) pNIA3b pSU1621 ACCGGATCCCGATGCTCAGTCACATGGT
CCAGAATTCACTCGATGGCCTTGGTTTG
    pCMS2 pNIA::TrwC (N293) pNIA3b pSU1621 ACCGGATCCCGATGCTCAGTCACATGGT
ACCGAATTCAGCTGAAATCTATGCCGAG
    pCMS5 pNIA::TrwC-NLS pNIA3b pSU1621 ACCGGATCCCGATGCTCAGTCACATGGT
CCAGAATTCTACCTACCTTTCTTTCCGGCCTCCATGCC
    pCMS9 pNIA::TrwC pNIA3b pSU1621 ACCGGATCCCGATGCTCAGTCACATGGT
ACCGAATTCACCTTCCGGCCTCCATGCC
    pCMS10 pNIA::TrwC (C774) pNIA3b pSU1621 CCAGGATCCTTGGAGCCGTCTATAAC
ACCGAATTCACCTTCCGGCCTCCATGCC
    pCMS15 pNEA::TrwC pNEA3b pCMS9 ACCGGATCCCGATGCTCAGTCACATGGT
CCACTCGAGACCTTCCGGCCTCCATGCC
    pCMS16 pNEA::TrwC (C774) pNEA3b pCMS10 CCAGGATCCTTGGAGCCGTCTATAAC
CCACTCGAGACCTTCCGGCCTCCATGCC
    pLA44 pNIA::TrwC*c pCMS10 pCMS9 Mutagenic PCRd
GGCTGGCGGTTGGGGGTTA
ACCGAATTCACCTTCCGGCCTCCATGCCGCG
    pLA66 pNIA::TrwC (A904T) pCMS10 pLA44 ACCGGATCCCGATGCTCAGTCACATGGT
ACCGAATTCACCTTCCGGCCTCCATGCC
    pMTX719 pNIA::NLS(x5)-TrwC pCMS9 Oligose GATCCCCAAGAAGAAACGGAAGGT
GATCACCTTCCGTTTCTTCTTGGG
    pMTX720 pNIA::NLS(x2)-TrwC pCMS9 Oligos GATCCCCAAGAAGAAACGGAAGGT
GATCACCTTCCGTTTCTTCTTGGG
    pMTX726 pNIA::NLS-TrwC pMTX719 None BamHI and religation
Plasmids used for immunofluorescence analyses
    pLA14 pCEFL::TrwC pCEFL pET29:trwAC ACCAAAGCTTATGCTCAGTCACATGGTATT
ACCAGGATCCTTACCTTCCGGCCTCCA
    pLA27 pCEFL::TrwC (N293) pCEFL pCMS3 BamHI/EcoRI
    pLA28 pCEFL::TrwC (N600) pCEFL pCIG1133 BamHI/EcoRI
    pLA29 pCEFL::TrwC (C774) pCEFL pCMS10 BamHI/EcoRI
a

†, mutation affecting the nic site (TCT/A-to-GAG/A change); ‡, human sequences in the indicated human chromosomes (HuX, -5, -18, or -7). The “n+n′” format indicates the extent of the consensus sequence around the nic site; variations from consensus are indicated in parentheses (see the text for details and nomenclature).

b

The first column (Vector) lists the vector plasmids, the second column (Insert) lists the plasmids from which the inserts were obtained, and the third column (Digestion/oligonucleotides) indicates either the restriction enzymes used for cloning or the oligonucleotides used for PCR amplification of the desired fragment, with the restriction sites underlined.

c

TrwC*, TrwC mutant obtained by random mutagenesis. It carries missense mutation A904T and the additional peptide KVNSCSHGSSRSTRD after residue 964 of TrwC.

d

This PCR was performed under mutagenic conditions, as described in Materials and Methods. The PCR fragment was digested with BamHI and EcoRI and ligated into the same sites of the pCMS10 backbone.

e

Oligos, oligonucleotides. NLS sequences were added to the N terminus of TrwC by oligonucleotide hybridization and insertion at BamHI site of pCMS9.